The UK at the forefront of innovative drug-radiotherapy combination clinical trials: introducing the CONCORDE platform
Affiliation
The Christie NHS Foundation Trust/University of Manchester, Manchester, UKIssue Date
2020
Metadata
Show full item recordCitation
Faivre-Finn C, Brown S, Ryan A, Greystoke A, Investigators C. The UK at the Forefront of Innovative Drug-Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform. Clin Oncol (R Coll Radiol). 2020.Journal
Clinical OncologyDOI
10.1016/j.clon.2020.02.003PubMed ID
32107107Additional Links
https://dx.doi.org/10.1016/j.clon.2020.02.003Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2020.02.003
Scopus Count
Collections
Related articles
- Concorde: ride quality and passenger reactions.
- Authors: Richards LG, Jacobson ID
- Issue date: 1978 Jul
- CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
- Authors: Walls GM, Oughton JB, Chalmers AJ, Brown S, Collinson F, Forster MD, Franks KN, Gilbert A, Hanna GG, Hannaway N, Harrow S, Haswell T, Hiley CT, Hinsley S, Krebs M, Murden G, Phillip R, Ryan AJ, Salem A, Sebag-Montefoire D, Shaw P, Twelves CJ, Walker K, Young RJ, Faivre-Finn C, Greystoke A
- Issue date: 2020 Nov
- How generalizable are the results of large randomized controlled trials of antiretroviral therapy?
- Authors: Moore DA, Goodall RL, Ives NJ, Hooker M, Gazzard BG, Easterbrook PJ
- Issue date: 2000 Jul
- Data and safety monitoring in the Concorde and Alpha trials.
- Authors: Armitage P
- Issue date: 1999 Jun